This site uses cookies to provide you with a more responsive and personalised service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.
The Health and Social Care Act 2012 presents an opportunity to transform the way in which healthcare for the homeless is commissioned, according to a new report from the Deloitte Centre for Health Solutions.
In the face of ongoing economic pressure and risk aversion, the evolution of partnering in drug development is leading to a reevaluated approach to biotechnology, according to Deloitte, the business advisory firm.
New analysis into the value generated by the research and development (R&D) carried out by leading pharmaceutical companies indicates that new approaches are needed if R&D is to be able to pay its way.
The corporate finance life sciences & health care team at Deloitte, the business advisory firm, is celebrating after being named Corporate Financier of the Year at this year’s HealthInvestor Awards ceremony.
A survey indicates that 61% of UK adults see improving the quality of care provided by doctors and hospitals as highly important in determining their support for political candidates.
Deloitte, the business advisory firm, has appointed corporate finance specialist Chris Britten as a director to its expanding UK Life Sciences & Healthcare practice.